Linaclotide ntsiav tshuaj

Shaanxi BLOOM Tech Co., Ltd. yog ib qho ntawm cov tuam ntxhab thiab cov muag khoom ntawm linaclotide ntsiav tshuaj hauv Suav teb. Txais tos rau cov lag luam wholesale bulk zoo linaclotide ntsiav tshuaj muag ntawm no los ntawm peb lub hoobkas. Kev pabcuam zoo thiab tus nqi tsim nyog muaj.

Linaclotide ntsiav tshuajsawv cev rau ib daim ntawv hais lus muab tshuaj noj tshwj xeeb uas tsim los muab cov peptide tsim nyog raws li kev ua kom muaj kev ruaj ntseg thiab yooj yim ntawm kev siv rau cov neeg mob. Cov khoom lag luam tiav no siv cov txheej txheem tsim khoom kom paub tseeb tias cov khoom zoo sib xws, cov txiaj ntsig kho tau zoo, thiab qhov chaw- tso tawm tshwj xeeb hauv cov hnyuv.

Linaclotide COA

 

 

1.Qhov sib txawv ntawm Mechanism of Action

Lub ntsiab analgesic mechanism ntawm nonsteroidal anti- tshuaj inflammatory (NSAIDs) dav siv nyob rau hauv kev kho mob xyaum, xws li ibuprofen, yog inhibit qhov kev ua ntawm cyclooxygenase (COX) thoob plaws hauv lub cev, yog li txo cov synthesis ntawm prostaglandins, ib tug tseem ceeb inflammatory mediator. Prostaglandins yog cov khoom tseem ceeb uas kho qhov mob thiab inflammatory teb; Los ntawm kev thaiv nws cov tiam, nws tsis tuaj yeem tsuas thaiv qhov kev sib kis ntawm cov cim mob mus rau hauv nruab nrab lub paj hlwb kom ua tiav cov kab mob analgesia, tab sis kuj tseem siv cov tshuaj tiv thaiv tseem ceeb - inflammatory los daws qhov mob stimuli los ntawm qhov mob, nrog rau nws lub hom phiaj npog ntau yam ntaub so ntswg thiab kab mob thoob plaws hauv lub cev.

Nyob rau hauv sib piv, lub mechanism ntawm kev txiav txim ntawmlinaclotide ntsiav tshuajyog cov neeg hauv zos heev. Cov tshuaj no tsis nkag mus rau hauv cov hlab ntsha thiab tsuas yog ua rau guanylate cyclase C (GC-C) receptor nyob rau ntawm lub plab hnyuv epithelial hlwb. Nws inhibits kev cog lus ntau dhau ntawm txoj hnyuv du thiab softens cov quav los ntawm kev tsim cov cyclic guanosine monophosphate (cGMP), txo cov plab hnyuv nro thiab txo cov hnyuv mucosal rhiab heev. Nws tsuas yog tswj lub zos pathological xeev ntawm txoj hnyuv.

2.Qhov sib txawv hauv Kev Qhia Hom Mob plab

Daim ntawv thov dav dav ntawm lwm cov tshuaj txo qhov mob yuav nyob deb dhau ntawm cov tshuaj benazepril, thiab cov saum toj no -hais ibuprofen yog ib qho ntawm cov tsos mob nyiam rau kev kho mob ntawm ntau yam mob plab. Nws tuaj yeem txo ntau yam mob plab uas cuam tshuam nrog kev mob los yog raug mob, nrog rau mob plab mob tshwm sim los ntawm kab mob gastroenteritis, mob plab plab tshwm sim los ntawm thawj dysmenorrhea los yog endometriosis, mob dull mob tom qab phais plab, thiab kev koom tes app mob los ntawm inflammatory kab mob xws li cholecystitis los yog cholecystitis.

Nyob rau tib lub sijhawm, nws tuaj yeem txo qhov tsis mob plab xws li mob taub hau, mob hniav, thiab mob pob qij txha.
Nyob rau hauv sib piv, lub analgesic ntau yam ntawmlinaclotidetshwj xeeb heev thiab tsim nyog rau qhov mob plab plab tshwm sim los ntawm cem quav predominant irritable bowel syndrome (IBS-C), uas yuav tsum tau nrog cov tsos mob ntawm plab hnyuv tsis ua hauj lwm xws li cem quav thiab tsam plab.

 

 

3.Qhov txawv ntawm cov yam ntxwv ua tau zoo

Kev kho kom zoo dua ntawm linaclotide nyob rau hauv nws cov tsos mob - thiab - hauv paus - ua rau ob lub - lub hom phiaj mechanism. Txawm hais tias nws muaj qhov pib ua haujlwm qeeb qeeb, feem ntau xav tau 2 mus rau 4 hnub ntawm kev noj tshuaj tas mus li kom ua tiav cov kev mob plab, cov tshuaj tsis zoo tsuas yog txo qhov mob plab, tab sis kuj tseem cuam tshuam txog cov teeb meem hauv plab hnyuv xws li cem quav thiab tsam plab. Los ntawm kev ua haujlwm hauv zos hauv cov hnyuv los tswj cov leeg nqaij du thiab cov hlab ntsha rhiab heev, linaclotide ua rau cov tsos mob zoo li qub nrog tus nqi qis dua tom qab kev kho mob tsis tu ncua. Txoj kev tswj hwm no uas tsom mus rau qhov tshwm sim ua rau nws muaj qhov tshwj xeeb ntev - lub sijhawm tswj hwm tus nqi hauv kev kho qee yam kev ua haujlwm ntawm lub plab tsis zoo xws li chim siab plob tsis so tswj nrog cem quav (IBS-C).

4.Qhov txawv ntawm qhov tsis zoo tshwm sim thiab contraindications

Cov kev phiv tsis zoo ntawm lwm cov tshuaj analgesics, xws li ibuprofen feem ntau yog cov teebmeem hauv lub cev, uas muaj feem cuam tshuam nrog ntau npaum li cas thiab lub sijhawm ntawm cov tshuaj. Luv -Lub sij hawm tswj hwm ntawm cov koob tshuaj yuav ua rau cov tsos mob plab hnyuv xws li mob plab, xeev siab thiab acid reflux; ntev- siv sijhawm ntev lossis siv ntau dhau yuav ua rau muaj kev pheej hmoo ntawm plab hnyuv thiab plab hnyuv los ntshav, thiab tseem tuaj yeem ua rau lub siab thiab lub raum ua haujlwm puas tsuaj, thaum inhibiting platelet aggregation thiab cuam tshuam rau cov ntshav coagulation. Qhov ntau ntawm contraindicated pejxeem rau ibuprofen kuj yog dav, nrog rau cov neeg mob uas muaj gastric ulcer thiab duodenal rwj, cov neeg uas muaj mob hnyav thiab lub raum tsis ua hauj lwm, cov neeg mob uas muaj coagulation dysfunction, cov neeg tsis haum rau cov uas tsis yog -steroidal anti- tshuaj inflammatory, raws li zoo raws li nyob rau hauv lub thib peb trimester ntawm cev xeeb tub.

Nyob rau hauv sib piv, qhov tsis zoo tshwm sim ntawmlinaclotide ntsiav tshuajfeem ntau yog cov kab mob hauv cov hnyuv hauv zos, nrog rau mob raws plab yog qhov tshwm sim ntau tshaj plaws, uas feem ntau tshwm sim thaum ntxov ntawm kev kho mob thiab tuaj yeem maj mam zam, yuav luag tsis ua rau muaj kev mob tshwm sim. Nws cov neeg contraindicated tsuas yog cov neeg mob uas muaj kev cuam tshuam ntawm lub plab zom mov, cov menyuam yaus hnub nyoog qis dua 6 xyoo, thiab cov tib neeg tsis haum rau cov khoom xyaw tshuaj, nrog kev txwv tsawg dua rau cov neeg siv piv nrog ibuprofen.

Early Scientific Foundations hauv Tebchaws Meskas (1980s-1990s)

Cov kev tshawb fawb hauv paus rau Linaclotide tau ua los ntawm cov tsev kawm ntawv hauv Tebchaws Meskas. Lub Tsev Kawm Ntawv Qib Siab Texas Health Science Center ntawm Houston, nrog rau lwm lub chaw tshawb fawb, tau piav qhia nws cov txheej txheem tseem ceeb. Kev tshawb fawb tseem ceeb hauv xyoo 1990, tau txais nyiaj los ntawm Lub Tsev Haujlwm Saib Xyuas Kev Noj Qab Haus Huv Hauv Tebchaws, tau tsim cov hauv paus rau kev tsim qauv ntawm cov khoom siv hluavtaws thaum lub sijhawm no.

Peptide Engineering thiab Clinical Development (Late 1990s – Mid-2000s)

Thaum xyoo 1990s, lub tuam txhab biotechnology Microbia, nyob hauv Cambridge, Massachusetts, tau nkag mus rau theem tsim tshuaj thiab tom qab ntawd los ua Ironwood Pharmaceuticals, ua lub teb chaws. Cov kws tshawb fawb ntawm Ironwood Pharmaceuticals tau qhia ntau yam disulfide daim ntawv cog lus kom ua raws li cov qauv nquag ntawm cov enterotoxins thaum sib tham txog kev ruaj ntseg tiv thaiv enzymatic degradation hauv plab. Kev tshawb fawb ntau hauv vitro thiab tsiaj txhu tau ua nyob rau hauv cov chaw hauv Boston cheeb tsam tau lees paub qhov ua tau zoo ntawm cov neeg siv tshuaj. Lub sijhawm no, Microbia (Ironwood Pharmaceuticals) tau hloov pauv lub tswv yim kev tshawb fawb mus rau hauv tus neeg sib tw ua haujlwm tau zoo.

Kev Txhim Kho Kho Mob, Kev Tsim Kho Tshiab, thiab Kev Pom Zoo Kev Cai (Mid-2000s-2012)

Cov theem kawg ntawm txoj kev loj hlob tau tsom mus rau kev txhais cov peptide rau hauv kev nyab xeeb thiab zoo tib neeg kev kho mob, tshwj xeeb hauv cov ntsiav tshuaj. Ib qho tseem ceeb hauv kev kho mob thiab kev tsim kho kev sib koom tes tau tsim los ntawm Ironwood Pharmaceuticals thiab New York-based Forest Laboratories. Pivotal Phase III kev sim tshuaj tau ua nyob rau ntau lub chaw tshawb fawb thoob plaws North America thiab Europe thaum xyoo 2000s los soj ntsuam cov tshuaj ua tau zoo thiab kev nyab xeeb. Tom qab kev sim ua tiav, Daim Ntawv Thov Tshuaj Tshiab tau raug xa mus rau cov thawj coj tswj hwm. Xyoo 2012, US Food and Drug Administration (FDA) hauv Silver Spring, Maryland, tau pom zooLinaclotide ntsiav tshuaj, kos npe rau lawv txoj kev vam meej los ntawm kev tshawb fawb hauv chav kuaj mus rau cov khoom lag luam muag tshuaj.

01

Manufacturing Scalability

Cov txheej txheem tsim kho hluavtaws thiab ua kom huv huv- feem ntau yog tso siab rau cov khoom siv -theem peptide synthesis (SPPS) thiab thim rov qab-theem siab-kev ua haujlwm ua kua chromatography (RP-HPLC)- xyuas kom cov khoom tsim tawm tau zoo heev thiab zoo ib yam loj heev.{6} Cov txheej txheem txheej txheem no ua rau muaj kev lag luam tsim tau zoo thaum ua tau raws li cov kev xav tau ntawm cov tshuaj zoo rau purity, potency, thiab batch-rau-batch uniformity.

02

Stability-Engineered Design

Cov tshuaj enteric-coated ntsiav tshuaj yog tsim tshwj xeeb los tiv thaiv cov kua qaub-sensitive peptide los ntawm degradation nyob rau hauv lub plab acidic ib puag ncig. Qhov kev tsim no ua kom cov peptide nyob twj ywm tsis tu ncua los ntawm lub plab hnyuv sab sauv thiab tso tawm tsuas yog nyob rau hauv nruab nrab- mus rau -alkaline tej yam kev mob ntawm cov hnyuv me, yog li xa cov khoom xyaw nquag mus rau nws qhov chaw ua haujlwm- lub plab hnyuv lumen, qhov twg GC receptors {6}.

Linaclotide sawv cev rau kev ua tau zoo ntawm cov kws kho mob uas ua ke nrog kev sib xyaw peptide nrog kev tsim cov ntsiav tshuaj siab heev. Lawv cov txheej txheem tsim khoom pib nrog cov khoom muaj zog-theem peptide synthesis, ua raws li siab -purity purification thiab lyophilization ntawm cov khoom xyaw nquag. Cov txheej txheem yog tom qab ntawd tsim kho rau hauv enteric-cov ntsiav tshuaj coated los ntawm kev tswj granulation, compression, thiab cov yeeb yaj kiab tshwj xeeb- txheej, ua kom muaj kev tiv thaiv peptide los ntawm kev zom zaub mov thiab tsom tso rau hauv txoj hnyuv. Txoj kev tsim khoom no tsis yog tsuas yog ua kom muaj kev ruaj ntseg thiab rov tsim dua tshiab tab sis kuj ua piv txwv li cas cov cuab yeej siv niaj hnub no tuaj yeem txhais cov kev kho peptide nyuaj rau hauv kev ntseeg siab, tus neeg mob- npaj cov ntawv noj qhov ncauj. Kev txhim kho tsis tu ncua hauv kev tsim khoom thiab kev tswj xyuas zoo txuas ntxiv txhim kho cov ntsiav tshuaj lub luag haujlwm raws li kev kho tseem ceeb hauv kev tswj kev noj qab haus huv digestive.

Cim npe nrov: linaclotide ntsiav tshuaj, lwm tus neeg, manufacturers, hoobkas, lag luam wholesale, yuav, nqe, tej, kev muag khoom